Home  >  Products  >  MGLL (monoglyceride lipase) Blocking Peptide (the N terminal of MGLL)(100ug)
MGLL (monoglyceride lipase) Blocking Peptide (the N terminal of MGLL)(100ug)

MGLL (monoglyceride lipase) Blocking Peptide (the N terminal of MGLL)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MGLL Antibody(ARP52321_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP52321
Size: 100ug
Weight: 34kDa
Gene: 11343
Format: Lyophilized powder
Target: Monoglyceride lipase (MGLL; EC 3.1.1.23) functions together with hormone-sensitive lipase (LIPE; MIM 151750) to hydrolyze intracellular triglyceride stores in adipocytes and other cells to fatty acids and glycerol. MGLL may also complement lipoprotein lipase (LPL; MIM 238600) in completing hydrolysis of monoglycerides resulting from degradation of lipoprotein triglycerides (Karlsson et al., 2001 [PubMed 11470505]).
Alternative names: HU-K5; MGL
See Full Product Listings >